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ABSTRACT 
Wegener’s granulomatosis (WG) is strongly associated with the presence of anti- 
neutrophil cytoplasmic autoantibodies (ANCA). Within WG these ANCA are in most 
cases (80-90%) directed against the azurophilic enzyme proteinase 3, so called PR3-
ANCA. A pathophysiological role for these autoantibodies, supported by numerous in 
vitro and in vivo studies, is particularly based on their capacity to bind and activate 
neutrophils and may, as such, potentially damage vessels.  
In this review, the pathogenic potential of different developmental stages of the 
neutrophil in the pathogenesis of WG is discussed. After release from the bone marrow 
into the circulation, neutrophils can be primed by TNF-α and become attached to 
locally activated endothelium. Once attached to endothelium ANCA can fully activate 
these primed neutrophils. In this activation process, the degree of activation after 
stimulation with PR3-ANCA associates with the level of PR3 expression on the 
membrane of the neutrophil. Following activation, infiltrated neutrophils become 
apoptotic with further membrane expression of PR3. In WG patients clearance of 
apoptotic neutrophils can be disturbed, due to opsonisation of PR3-expressing 
apoptotic neutrophils with PR3-ANCA, thereby perpetuating inflammation by release 
of pro-inflammatory cytokines during clearance, or it may favour autoimmunity by 
PR3 presentation in an inflammatory environment. Furthermore, the presence of 
ANCA and the release of the vessel-related pentraxin PTX3 may lead to the 
persistence of late apoptotic neutrophils in tissues, thereby inducing leukocytoclastic 
lesions that are characteristic for patients with WG. All together, alive neutrophils as 
well as apoptotic neutrophils play a key role in different inflammatory phenomena 
seen in patients suffering from Wegener’s granulomatosis. 
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INTRODUCTION 
ANCA-associated vasculitis 
The antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides (AAV) 
are a group of autoimmune diseases characterized by necrotizing inflammation of 
arterioles, venules, and capillaries, although larger vessels may be involved as well 1. 
These autoantibodies are in most cases directed against the azurophilic granule 
proteins proteinase 3 (PR3) or myeloperoxidase (MPO) of the neutrophil designated as 
PR3-ANCA and MPO-ANCA, respectively. Based on histopathological and clinical 
manifestations the Chapel Hill international consensus conference defined three major 
categories of AAV: Wegener’s Granulomatosis (WG), microscopic polyangiitis 
(MPA), and Churg Strauss syndrome (CSS). PR3-ANCA are found in 80 - 90% of 
WG patients, to a lesser extent in patients with MPA and incidentally in CSS 2;3. In 
patients with MPA and CSS, MPO-ANCA are the dominant autoantibodies but they 
occur in a minority of WG patients as well 2;3 . 
 These ANCA are supposed to play an important role in the pathogenesis of AAV. 
Their pathophysiological role is supported by clinical data, animal experimental 
models and in vitro data, which has been reviewed in various papers 2, 4-6. Clinically, 
ANCA titers have been shown to correlate, although not uniformly, with disease 
activity. Specifically, an increase in ANCA titer frequently preceeds a relapse whereas 
a decline in titer is seen when remission is induced. In animal models the 
pathophysiological role of ANCA has been supported by demonstrating that transfer of 
splenocytes from MPO-deficient mice immunized with MPO to Rag2-deficient mice, 
which lack functional B and T lymphocytes, led to the development of severe 
necrotizing and crescentic glomerulonephritis 7. Additionally, direct intravenous 
injection of anti-MPO antibodies, derived from MPO-immunized MPO deficient mice, 
into wild type or Rag2-deficient mice resulted in focal necrotizing glomerulonephritis. 
Finally, in vitro studies have shown that ANCA are capable of activating neutrophils 
leading to a respiratory burst and degranulation of noxious proteolytic enzymes which 
may induce endothelial injury 8-10.  
 
Activated neutrophils within ANCA-associated vasculitis 
The hypothetical model on how these ANCA activate neutrophils and harm the 
endothelium could be formulated as follows. First, neutrophils need to be primed with 
a low dose of tumor necrosis factor-α (TNF-α) to upregulate surface expression of the 
autoantigens PR3 and MPO in order to allow ANCA binding. However, probably 
more importantly, next to surface expression of autoantigens, priming facilitates 
clustering of FcγRIIa and β2 integrins and formation of the NADPH oxidase complex. 
Secondly, neutrophils need to a have an adhesive state as reflected by CD11b/CD18 
expression. Finally, when neutrophils are primed and firmly adhere to TNF-α 
activated endothelium, ANCA can fully activate neutrophils resulting in degranulation 
and reactive oxygen species (ROS)-production eventually leading to injury of the 
vessels. In this activation process, F(ab’)2  fragments of ANCA bind to their 
autoantigen, PR3 or MPO, whereas the Fc parts of ANCA interact with neutrophil 
Fcγ-receptors resulting in full activation although F(ab’)2 fragments of ANCA alone 
have been shown to induce minor activation as well 11.  
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In biopsies from WG patients it has been shown that neutrophils are really present and 
activated at sites of injury. These histological studies from the upper airways of 
Wegener’s patients demonstrated large numbers of activated, apoptotic and necrotic 
neutrophils in the early development of vasculitis 12. Furthermore, in renal infiltrates 
neutrophils are present next to monocytes4;5. In addition, the activated state of 
neutrophils and extracellular localization of lysosomal enzymes was demonstrated in 
renal biopsies from patients with WG, and numbers of activated neutrophils present in 
renal biopsies correlated wit renal tissue damage 13.  
So, neutrophils seem to play an important role in the pathogenesis of ANCA-
associated vasculitis. Therefore, the key role of neutrophils during their cycle of 
activation, apoptosis and clearance will be discussed in this review. In this the focus 
will be on neutrophils in PR3-ANCA-associated vasculitis. 
 
PR3 expression and activation 
PR3 is a serine protease mainly stored in the azurophilic granules of neutrophils, but it 
can be found in the specific and secretory vesicles as well 15. Moreover, PR3 can also 
be constitutively present on resting neutrophils. Priming of neutrophils with low dose 
of TNF-α facilitates fusion of secretory vesicles and specific granules resulting in a 
two- to three-fold upregulation of PR3 expression on the membrane of the neutrophil 
68. PR3 can be expressed on the membrane (mPR3) of the total population or on a 
subset of neutrophils (Figure 1) 15-18. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Patterns of PR3 surface expression on resting neutrophils. A) mPR3- donor, B) mPR3-/+ or 
bimodal donor, and C) PR3+ donor. The bold line represents cells staining with anti-PR3 antibody, 
whereas the thin line represents non-specific binding. 
 
Individuals can be categorized according to their pattern of mPR3 expression on their 
resting neutrophils into those in whom all neutrophils express none to only minor 
levels of mPR3 (mPR3- individuals), individuals in whom all neutrophils express 
substantial levels of mPR3 (mPR3+ individuals), and so-called bimodal individuals in 
whom two subsets are present, that is a subset of neutrophils expressing none to minor 
levels of mPR3 and a subset expressing substantial levels of mPR3 (mPR3-/+). This 
pattern seems to be genetically determined 19. Interestingly, bimodal expression is not 
seen for elastase or other neutrophil markers. Various groups 18-20 have studied the 
clinical significance of this differential mPR3 expression on neutrophils. Patients with 
PR3-ANCA associated vasculitis have an inreased expression of mPR3 on their resting 
neutrophils as compared to healthy individuals. Furthermore, Rarok et al demonstrated 
 
 A. B. C. 
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that an increased expression of mPR3 in vasculitis was associated with an increased 
incidence and rate of relapse7. In further in vitro studies, the functional significance of 
mPR3 expression for neutrophil activation after stimulation with anti-PR3 antibodies 
was analysed 8;9. We studied healthy individuals with different patterns of mPR3 
expression and measured actin polymerization in neutrophils, as an early event in 
neutrophil activation after stimulation with anti-PR3 antibodies10. It proved that even 
unprimed neutrophils can be activated by anti-PR3 antibodies, as measured by their F-
actin polymerization. More importantly, levels of mPR3 expression were associated 
with the degree of F-actin polymerization after stimulation with anti-PR3 antibodies, 
further supporting the relation between mPR3 expression and susceptibility for 
relapses in patients with WG 17. Thus, increased mPR3 expression on neutrophils in 
WG is a risk factor for relapse, probably due to increased sensitivity for becoming 
activated by PR3-ANCA. 
 
Effects of apoptosis on PR3 expression of neutrophils 
The fate of neutrophils after activation is apoptosis. Apoptosis is a genetically 
programmed cell suicide, characterized by condensation of cytoplasm and intracellular 
organelles, cleavage of nuclear chromatin, and formation of apoptotic bodies with or 
without nuclear remnants 11. During induction of apoptosis several genes encoding 
proinflammatory factors, signal transduction mediators, adhesion molecules, and other 
inflammation-related proteins are down-regulated 12. Several groups have studied 
changes in the expression of the autoantigens PR3 and MPO on neutrophils and 
basophilic cells during apoptosis 24-29. When PR3 and MPO would be upregulated 
during apoptosis, this could provide an alternative mechanism for ANCA to interact 
with neutrophils. Gilligan et al were the first to show that, in the absence of priming, 
ageing neutrophils can translocate PR3 or MPO to the membrane during the apoptotic 
process, as assessed by increased ANCA binding 13. Using electron microscopy, 
translocation to the membrane of cytoplasmic granules, containing PR3, was 
demonstrated, suggesting that upregulation of the autoantigen was due to translocation 
of these granules. Four years later, Yang et al observed that incubation of neutrophils 
per se is already sufficient to translocate ANCA antigens. In that study, unstimulated 
neutrophils show increased ANCA antigen expression on the membrane after 4 hrs 
incubation, whereas those cells do not show signs of apoptosis 14. In addition, ageing 
of neutrophils for 24 hrs, by which 30% became apoptotic, resulted in increased 
expression of ANCA antigens. However, no significant difference in autoantigen 
expression could be found between apoptotic and non-apoptotic cells, implying that 
upregulation of these autoantigens was merely a result of priming by minor trauma 
resulting from in vitro incubation. In another study 27, apoptosis in neutrophils was 
accelerated by a low dose of TNF-α (10 ng/ml) in combination with the protein 
synthesis inhibitor cycloheximide. By this method, the pro-apoptotic effect of TNF-α 
is pronounced whereas anti-apoptotic effects exerted via the NF-κB pathway are 
blocked by cycloheximide. TNF-α-accelerated apoptotic neutrophils showed increased 
PR3 and MPO expression compared to TNF-α- primed alive neutrophils 27. However, 
increase of PR3 and MPO expression was only seen in a small proportion of apoptotic 
neutrophils, probably leaky neutrophils, whereas most apoptotic neutrophils showed 
no increase in cell surface expression. We may conclude from these studies that PR3 
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and MPO remain on the membrane of neutrophils during apoptosis and are accessible 
for ANCA. However, whether apoptosis intrinsically upregulates expression of these 
autoantigens on the cell membrane of neutrophils is not conclusive yet.  
 
Apoptotic neutrophils in vasculitis 
In ANCA-associated vasculitis neutrophils from the peripheral blood show increased 
apoptosis after incubation in vitro 15. In fact, these neutrophils are more primed, as 
assessed by increased ANCA-induced superoxide production, and they have increased 
expression of PR3 on their membrane in comparison to neutrophils of healthy controls. 
Ageing of neutrophils up to 24 hrs results in a decreased ability to produce superoxide 
upon stimulation with ANCA as well as with other potent stimuli 15. Accelerating 
apoptosis by TNF-α results in further abrogation of ANCA-mediated oxidative burst 
in neutrophils, which appears to be caspase-3 dependent 16. Also, ANCA itself have 
been shown to accelerate apoptosis of neutrophils. In a study of Harper et al, TNF-α-
primed neutrophils incubated with IgG purified from ANCA-containing sera showed 
accelerated apoptosis compared to control IgG, a process which was dependent on 
oxygen radical generation17. Interestingly, neutrophils in which accelerated apoptosis 
was induced by ANCA showed typical features of apoptosis such as shrunken nuclei 
and internucleosomal cleavage of DNA but no increased externalization of 
phosphatidylserine. Thus, ANCA induce increased apoptosis of neutrophils in AAV. 
These apoptotic neutrophils show upregulated surface expression of PR3, are, as such, 
accessible by ANCA, but cannot be stimulated to superoxide production by ANCA.  
 
Clearance of neutrophils in an inflammatory context 
Apoptotic neutrophils are recognized by phagocytic cells, resulting in their clearance 
by phagocytes. Clearance is a process of engulfment and digestion of apoptotic cells, 
mainly executed by macrophages in tissues. Apoptotic cells are recognized by their 
expression of certain surface membrane molecules, mostly altered carbohydrates or 
phospholipids. A crucial phospholipid in the recognition of apoptotic cells is 
phosphatidylserine 18-22. Normally, uptake of apoptotic cells by macrophages coincides 
with suppression of pro-inflammatory cytokines such as TNF-α and enhanced 
production of anti-inflammatory cytokines such as TGFβ, PGE2, and PAF through 
autocrine and paracrine mechanisms 23. In this way, clearance is safe and inflammation 
prevented. However, in ANCA-associated vasculitis autoantibodies can opsonize 
apoptotic neutrophils that express PR3 or MPO, leading into an enhanced uptake and 
production of pro-inflammatory cytokines as IL-1, IL-8 and TNF-α 15;24. As a result, 
clearance is unsafe and inflammation perpetuates. Another, potentially harmful, 
mechanism associated with opsonization by autoantibodies in an inflammatory context 
is the potential breakdown of tolerance, resulting in autoimmunity. Whether tolerance 
or immunity is established depends on the maturity state of the dendritic cells (DC). 
Immature DCs that internalize necrotic or apoptotic cells, needs maturation signals to 
mature. Maturation signals include lipopolysaccharide, interferon-α and TNF-α. 
Basically, T-cell tolerance is induced when apoptotic cells are engulfed in the absence 
of maturation signals. In contrast, T-cell activation and immunity may result when 
DCs ingest necrotic or apoptotic cells, for instance during a viral infection, leading to 
release of maturation signals that induce upregulation of MHC class II, and 
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subsequently presentation of (auto) antigenic peptides in a MHC class II-restricted 
manner to T-cells. Interestingly, opsonisation of apoptotic cells with anti-β2-
Glycoprotein I (GPI) autoantibodies facilitated MHC class II- antigen presentation by 
DCs 25. In addition, DCs that were challenged with anti-β2-GPI- opsonized apoptotic 
cells secreted interleukin-1β (IL-1β), TNF-α and IL-10, as such increasing 
immunogenicity of these apoptotic cells. Clayton et al. studied the effects of apoptotic 
and necrotic neutrophils on the phenotype of dendritic cells and their ability to 
stimulate allogeneic T cell proliferation 26. They showed that internalization of 
apoptotic and necrotic neutrophils by immature dendritic cells results in upregulation 
of CD83 and MHC class II, whereas CD40, CD80 and CD86 were downregulated 
resulting in a decreased ability to stimulate T cell proliferation. However, in the 
presence of TNF-α downregulation of these maturation markers after engulfment of 
apoptotic neutrophils was overcome to some extent, suggesting that apoptotic 
neutrophils in combination with cytokines at sites of inflammation may favor the 
development of autoimmunity. That apoptotic neutrophils under inflammatory 
conditions can be autoimmunogenic has been shown by a study of Patry et al27. They 
showed that injection of syngeneic apoptotic neutrophils into Brown Norway rats 
resulted in the development of ANCA, although the rats did not develope disease. 
Thus, clearance of apoptotic neutrophils opsonized by ANCA will result in an 
inflammatory reaction, which promotes autoantigen presentation and, as such, 
augments the autoimmune response.  
 
Disturbances in the clearance of neutrophils 
In WG, 40 - 50% of the patients have cutaneous manifestations which are 
histopathologically, in most cases, defined as leukocytoclastic vasculitis (Figure 2) 
28;29. Leukocytoclastic vasculitis is characterized by infiltration and accumulation of 
unscavenged apoptotic or necrotic neutrophils or fragmented nuclei of neutrophils in 
the tissues around the vessels (leukocytoclasia), and swelling of endothelial cells 
accompanied by fibrinoid necrosis of vessel walls 30. Leukocytoclastic lesions are 
primarily found in the skin but other organs may be involved as well. Recent studies 
on the nature of the neutrophilic infiltrate showed strong positive staining with in situ 
nick end labeling techniques, thereby demonstrating DNA breakdown in the 
infiltrating neutrophils. In these lesions, only a minor part is typical apoptotic, whereas 
organelles and the majority of neutrophils shows breakdown of DNA with 
disintegrated cytoplasmic plasma membrane 31;32. The phenomenon of leukocytoclasia 
is interesting, since normally dying cells are quickly engulfed by phagocytes, 
particularly at sites of inflammation. Furthermore, accumulation of dying cells and the 
presence of nuclear debris in these lesions suggest that the removal of apoptotic or 
necrotic cells is incomplete. Pentraxins have been shown to be involved in the removal 
of dying cells44. Classical pentraxins such as serum amyloid P (SAP) and C-reactive 
protein (CRP) bind to apoptotic cells in a calcium-dependent manner 33;34. 
Subsequently, opsonisation with CRP or SAP results in increased binding of the 
complement component C1q, thereby facilitating uptake 47,48. In addition, Bijl et al 
showed that SAP binds specifically to late apoptotic cells and regulate their clearance 
by macrophages 35. In contrast, another pentraxin, PTX3, seems to inhibit instead of  
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Figure 2. Histological specimen of leukocytoclastic vasculitis in the skin with infiltrating neutrophils, 
nuclear dust and fibrinoid necrosis of the vessel (hematoxylin-eosin, x 100). 
 
facilitate uptake of apoptotic cells 36;37. In view of the persistence of apoptotic 
neutrophils in leukocytoclastic vasculitis, the role of PTX3 in this phenomenon was 
further explored. 
 
PTX3 in vasculitis 
In vasculitic patients PTX3 levels correlate, independently from CRP, with disease 
activity 38-40. PTX3 is produced locally at sites of inflammation under the control of 
pro-inflammatory signals, by endothelial cells, fibroblasts but also cells of the 
monocytic lineage 41-43. PTX3 binds specifically to dying cells, either necrotic or 
apoptotic 36, although binding of PTX3 to necrotic cells is less intense than to 
chemically or spontaneously induced apoptotic cells. Interestingly, human dendritic 
cells failed to phagocytose apoptotic cells in the presence of PTX3 36. In that same 
study, Rovere et al showed that PTX3 can bind to apoptotic neutrophils as well, 
however, only to late apoptotic neutrophils and not to vital or early apoptotic 
neutrophils. Subsequently, we showed that phagocytosis of late apoptotic neutrophils 
by macrophages was dose-dependently inhibited in the presence of PTX3, whereas 
SAP facilitated phagocytosis 37. The inhibitory capacity of PTX3 on the clearance of 
late apoptotic neutrophils may explain for the persistence of apoptotic and necrotic 
cells at sites of leukocytoclastic lesions. However, PTX3 only inhibits the clearance of 
late apoptotic neutrophils. In other words, early apoptotic neutrophils should be 
normally engulfed by phagocytes, particularly in inflammatory tissue. So, where do 
these late apoptotic or secondary necrotic neutrophils come from. A possible 
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explanation comes from a study of Harper et al in which TNF-α-primed neutrophils 
incubated with IgG purified from ANCA–containing sera showed accelerated 
apoptosis compared to neutrophils incubated with control IgG 17. The former 
neutrophils showed typical features of apoptosis as shrunken nuclei and 
internucleosomal cleavage of DNA but no increased externalization of 
phosphatidylserine. Furthermore, these neutrophils were less well phagocytosed 
compared to apoptotic neutrophils incubated with control IgG, possibly due to 
defective phosphatidylserine expression. 
Taken together, ANCA and PTX3 both seem to be able to disturb normal clearance of 
apoptotic neutrophils by macrophages, as such being candidate factors in the 
development of leukocytoclastic phenomena in vasculitis.  
 
 
CONCLUSION 
Neutrophils are key players in the pathogenesis of Wegener’s Granulomatosis. At sites 
of injury neutrophils are present and their numbers correlate with damage. PR3-ANCA 
can activate these cells and, possibly, induce tissue damage. However, this is not all. 
The pathological potential of neutrophils continues after their death. Apoptotic 
neutrophils, expressing PR3 on their membrane, can be opsonized by PR3-ANCA 
resulting in unsafe, pro-inflammatory clearance by macrophages and presentation of 
PR3 or MPO by dendritic cells. In addition, in WG clearance of apoptotic neutrophils 
is sometimes incomplete as shown by the persistence of apoptotic neutrophils 
(leukocytoclasia). In these phenomenon, ANCA and a novel, vessel-related pentraxin 
PTX3 are supposed to play a role.  In conclusion, the pathogenic potential of 
neutrophils may be exerted in WG during two stages of their lifetime: that is both in 
their vital and apoptotic state. Interaction of ANCA with vital neutrophils results in 
activation of these cells and tissue damage, whereas interaction with apoptotic 
neutrophils results in inflammatory clearance and boosting of the PR3- or MPO-
specific autoimmune response. 
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